---
title: "U.S. stock market update: Liminatus Pharma up 25.18%"
description: "Liminatus Pharma rose 25.18%; AbbVie rose 0.53%, with a trading volume of USD 784.3 million; Ethzilla fell 37.42%, with a trading volume of USD 610.7 million; Biohaven Pharmaceuticals rose 5.38%, with"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254192219.md"
published_at: "2025-08-22T13:37:48.000Z"
---

# U.S. stock market update: Liminatus Pharma up 25.18%

> Liminatus Pharma rose 25.18%; AbbVie rose 0.53%, with a trading volume of USD 784.3 million; Ethzilla fell 37.42%, with a trading volume of USD 610.7 million; Biohaven Pharmaceuticals rose 5.38%, with a trading volume of USD 240.8 million; Amgen rose 0.70%, with a market capitalization of USD 159.1 billion

**U.S. Stock Market Midday Update**

Liminatus Pharma, up 25.18%, with increased trading volume. Based on recent key news:

1.  On June 12, executives from China National Pharmaceutical Group revealed at the Goldman Sachs Global Healthcare Conference that a landmark external licensing deal is expected to be finalized soon, driving the stock price up.
    
2.  On May 19, a block trade occurred for Lino Pharmaceutical, with shareholders increasing their holdings, leading to a 14.25% rise in stock price.
    
3.  On May 20, a block trade occurred for TuoXin Pharmaceutical, resulting in a 0.89% increase in stock price.
    

**Stocks with High Trading Volume in the Industry**

AbbVie, up 0.53%, with increased trading volume. Based on recent important news:

1.  On August 22, AbbVie announced that its alopecia treatment drug Rinvoq achieved primary goals in two key late-stage trials, driving the stock price up 0.88%.
    
2.  On August 21, a large purchase of AbbVie stock was made on behalf of Ritchie Torres, boosting market confidence.
    
3.  On August 19, AbbVie completed its acquisition of Capstan Therapeutics, expanding its product line.
    

Ethzilla, down 37.42%, with a trading volume of $61.07 million. Based on recent key news:

1.  On August 22, Ethzilla shareholders applied to sell 74.8 million convertible shares, causing the stock price to drop nearly 38%.
    
2.  In August, Ethzilla completed a private placement, raising $425 million to purchase Ethereum and continue its iGaming business.
    
3.  In August, Ethzilla announced it holds 82,186 Ethereum, with an average acquisition price of $3,806.71, currently valued at approximately $349 million.
    

Biohaven Pharmaceuticals, up 5.38%, with increased trading volume. Based on recent important news:

1.  On August 22, Biohaven announced that its new drug troriluzole is expected to receive FDA approval by the end of the year, becoming the first drug to treat spinocerebellar ataxia, resulting in a 5.6% increase in stock price.
    
2.  On August 22, Biohaven submitted new drug application documents to the U.S. Securities and Exchange Commission, which was positively received by the market.
    
3.  On August 22, Biohaven's stock price rose 11.65% in pre-market trading, reflecting investor optimism about its new drug prospects.
    

**Stocks with High Market Capitalization in the Industry**

Amgen, up 0.70%, with a market capitalization of $159.1 billion, and increased trading volume. Based on recent key news:

1.  On August 21, Amgen released its latest financial report, showing that its quarterly revenue and profit exceeded market expectations, driving the stock price up 0.70%
    
2.  On August 20th, MarketBeat reported that although Amgen was rated as a hold, top analysts recommended five other stocks, leading some investors to reassess their portfolios.
    
3.  On August 22nd, the futures market was dominated by bulls, with the funding rate turning positive and the long-short ratio rising to 1.169, indicating an increase in bullish sentiment in the market, further supporting Amgen's stock price

### Related Stocks

- [LIMN.US - Liminatus Pharma](https://longbridge.com/en/quote/LIMN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 彭博新聞報道，康菲石油正在考慮出售其價值 20 億美元的二疊紀資產 | 2 月 20 日（路透社）- 據彭博新聞週五報道，康菲石油正在探索出售其部分二疊紀盆地資產，這是其更廣泛的投資組合精簡的一部分，消息人士透露。這些資產是通過與 Concho Resources 和 Shell（SHEL.L）的交易在多年中收 | [Link](https://longbridge.com/en/news/276478732.md) |
| 沃爾瑪四季度財報超預期但盈利指引不及預期，CEO 稱 “美國低收入家庭只能勉強維持生計” | 沃爾瑪 Q4 營收超預期，新財年盈利指引（每股 2.75-2.85 美元）遠低於市場預期的 2.96 美元，顯示通脹壓力下消費者支出不確定性猶存，拖累股價下跌 1.38%。財報印證 K 型” 分化：高收入家庭驅動增長，低收入羣體 “錢包吃緊 | [Link](https://longbridge.com/en/news/276398633.md) |
| 學習英偉達刺激芯片銷售，AMD 為 “AI 雲” 借款做擔保 | AMD 為擴大市場份額祭出金融 “狠招”！為初創公司 Crusoe 的 3 億美元購芯貸款提供擔保，承諾在其無客户時 “兜底” 租用芯片。這一復刻英偉達 “租卡雲” 路徑的策略雖能短期推高銷量，但也令 AMD 在 AI 需求放緩時面臨更大的 | [Link](https://longbridge.com/en/news/276401504.md) |
| 谷歌突然發佈 Gemini 3.1 Pro：核心推理性能直接翻倍 | 谷歌發佈了最新的大模型 Gemini 3.1 Pro，其推理性能較去年發佈的 Gemini 3 Pro 翻倍。在 ARC-AGI-2 評測中，Gemini 3.1 Pro 得分 77.1%，顯示出強大的推理能力。新模型支持多源數據綜合和複雜 | [Link](https://longbridge.com/en/news/276396515.md) |
| 最高法裁決後特朗普動用替補選擇：加徵 10% 全球關税 | 美國總統特朗普在最高法院裁決後宣佈將加徵 10% 的全球關税，以補救被推翻的關税措施。根據《1974 年貿易法》第 122 條款，現有的關税將全面生效。最高法院裁定特朗普政府的部分關税措施缺乏法律授權。市場風險提示，投資需謹慎。 | [Link](https://longbridge.com/en/news/276477629.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.